Skip to main content
Home
language-selector-globe Korea | ko
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Korea
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • 회사소개 
      • 주요 전략 
      • 직원과 기업문화 
      • 다양성과 포용성 
      • 제품정보  
      • 노바티스그룹 경영진 
      • 핵심 사업부문 
      • 연락처 
      About Novartis Korea 회사소개
    • 환자와 보호자 
      • 환자와 보호자에 대한 노바티스의 약속 
      • 주요 질병 분야 
      • 제품정보  
      • 부작용 보고 
      A couple holding hands 환자와 보호자
    • 의료전문가 
      • 메드허브 
      • 제품정보  
      • 부작용 보고 
      • 혁신 
      • 글로벌 정보서비스 
      Novartis Health Care 의료전문가
    • 혁신 
      • 임상시험 
      • 기술 플랫폼 
      • 데이터와 디지털 
      • 한국노바티스의 혁신 
      • 노바티스의 혁신 
      • 노바티스 생명의학연구소(NIBR) 
      Novartis Innovation 혁신
    • 환경, 사회 및 가브넌스 
      • 윤리 위험 및 규정준수 
      • 의약품 접근성 
      • 환경지속가능성 
      • 글로벌 헬스 
      • 윤리적 행동양식 
      • 한국노바티스의 사회적 책임 
      Novartis ESG 환경, 사회 및 가브넌스
    • 뉴스룸 
      • 보도자료  
      • 이노베이션 스토리  
      • 자료실 
        • 의약품 회수에 관한 공표 
      Novartis News 뉴스룸
    • 인재채용 
      • 채용 공고 
      • 우리가 일하는 방식 
      • 웰빙 
      • 다양성과 포용성  
      • 수상내역 
      Novartis Careers 인재채용
    • Coronavirus 
      multiple coronavirus illustration edit image_1 코로나바이러스감염증-19 (COVID-19) 업데이트
    Seoul Skyline Home
  1. Home
  2. 인재채용
  3. 채용 공고
  • Sort by Sort ascending
  • Job Title Sort descending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort descending Site Location Division Business Functional Area Date Posted
Quality Operations Specialist - Batch Release INSURGENTES Mexico Operations Innovative Medicines Quality Oct 07, 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA SF) Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA USP) Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
R2R Accountant Moscow (City) Russian Fed. Finance CTS Audit & Finance Jul 25, 2024
R2R Lead Israel Israel Israel Finance CTS Audit & Finance Sep 16, 2024
R2R Senior Specialist Bucuresti Romania Finance CTS Audit & Finance Sep 05, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 08, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Aug 19, 2024
R2R Senior Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Oct 02, 2024
R2R Senior Specialist GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Jun 13, 2024
R2R Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 15, 2024
R2R Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Jul 28, 2024
R2R Team Lead - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 10, 2024
RA CMC Associate Manager - II Hyderabad (Office) India Development Innovative Medicines Research & Development Jun 19, 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development May 30, 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
RA CMC Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
RA CMC Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
RA CMC Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
RA GDD Project Specialist London (The Westworks) United Kingdom Development Innovative Medicines Facilities & Administration Sep 10, 2024
RA Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Sep 03, 2024
RA Manager, Procedural Documents London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 10, 2024
RA Operational Excellence Junior Associate – MEA Dubai Utd.Arab Emir. Development Innovative Medicines Research & Development Oct 16, 2024
RA Specialist Croatia Croatia Development Innovative Medicines Research & Development Oct 18, 2024
Reability Engineer Targu Mures Romania Operations Innovative Medicines Technical Operations Aug 06, 2024
Real Estate & Service Management Specialist/Coordinator Kundl Austria Operations Innovative Medicines Facilities & Administration Sep 27, 2024
Real Estate Lead, Data & Technology Prague Czech Republic Operations CTS Facilities & Administration Oct 11, 2024
Real World Evidence Research Analyst Dublin (Novartis Corporate Center (NOCC)) Ireland Operations CTS Market Access Aug 12, 2024
Record to Report (R2R) Section Head New Cairo Egypt Finance CTS Audit & Finance Oct 18, 2024
Record to Report (R2R) Specialist New Cairo Egypt Finance CTS Audit & Finance Oct 18, 2024
Record to Report Specialist INSURGENTES Mexico Finance CTS Audit & Finance Sep 05, 2024
Record to Report Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Record to Report Sr Specialist Intercompany INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Record to Report Sr Specialist US INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
REFS Key Account & Business Relationship Manager Basel (City) Switzerland Operations CTS Facilities & Administration Aug 30, 2024
Regional Business Manager Mumbai (Head Office) India International Innovative Medicines Sales Sep 27, 2024
Regional Business Manager Tamil Nadu India International Innovative Medicines Sales Sep 27, 2024
Regional Business Manager Delhi (Office) India International Innovative Medicines Sales Sep 27, 2024
Regional Business Manager Madhya Pradesh India International Innovative Medicines Sales Sep 27, 2024
Regional Business Manager Bangalore (Office) India International Innovative Medicines Sales Oct 01, 2024
Regional Procurement Category Manager Real Estate Prague Czech Republic Operations CTS Procurement Oct 15, 2024
Regional Sourcing Manager APAC-Indirect (Japanese Speaker) Selangor Malaysia Operations CTS Procurement Jul 22, 2024
Regulatory Affairs CMC Associate Director Schaftenau Austria Development Innovative Medicines Research & Development Sep 30, 2024
Regulatory Affairs CMC Senior Manager Schaftenau Austria Development Innovative Medicines Research & Development Sep 02, 2024
Regulatory Affairs Manager New South Wales (NSW) Australia Development Innovative Medicines Research & Development Oct 06, 2024
Regulatory Affairs Manager Kyiv Ukraine Development Innovative Medicines Research & Development May 10, 2024
Regulatory Affairs Manager Beijing (Beijing) China Development Innovative Medicines Research & Development Sep 01, 2024
Regulatory Affairs Medical Device Manager (Schaftenau, Austria) Schaftenau Austria Development Innovative Medicines Research & Development Sep 02, 2024
Regulatory Affairs Systems & Strategy Manager London (The Westworks) United Kingdom Development Innovative Medicines Technology Transformation Sep 02, 2024
Renal Medical Lead Seoul South Korea International Innovative Medicines Research & Development Sep 01, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 42
  • › Next page

한국노바티스

Navigate Novartis
  • 회사소개
  • 환자와 보호자
  • 의료전문가
  • 혁신
  • 환경, 사회 및 가브넌스
  • 뉴스룸
  • 인재채용
Media Center
  • 보도자료
  • 이노베이션 스토리
Other Novartis Websites in Korea
  • MedHub
  • Novartis Global
  • 한국노바티스 LinkedIn
  • 한국노바티스 YouTube
Footer Bottom
© 2024 Novartis AG
  • 개인정보 처리방침
  • 이용약관
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
이 사이트는 국내 거주자들을 위한 사이트입니다. KR2205234431